13Feb
Ahead of the pack: US M&A 2019: Biotech boosts US healthcare M&A in 2019
The healthcare sector (incorporating pharma, medical and biotech) has seen M&A valued at US$256.5 billion across 645 deals in 2019. This is a decrease of 9 percent by volume, but an increase of 121 percent by value....
By:
White & Case LLP
Related
Compliance into the Weeds is the only weekly podcast which takes a deep dive into a compliance relat...
Read More >
Most deals are approved, but the landscape is becoming increasingly complex, as more types of transa...
Read More >
Estella Trammell was an at-will employee of AccentCare. She challenged the district court’s order r...
Read More >
Welcome to the 2019 Shearman & Sterling Antitrust Annual Report. Our seventh edition focuses on the...
Read More >
Beset by ongoing tariff wars, Brexit fallout, heightened sanctions, and other geopolitical tumult, g...
Read More >
The U.S. Department of Labor ("DOL") is one step closer to publishing final regulations on the FLSA'...
Read More >